Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains.

BACKGROUND To study the neuropathology and selected tumour markers of malignant gliomas, an animal glioma model was developed using the implantation of U87 human glioblastoma cells into chick chorioallantoic membrane. The immunohistochemical characteristics were studied and compared with an orthotopic rodent model. MATERIALS AND METHODS The U87 cell suspension was inoculated onto the chick chorioallantoic membrane on embryonic day seven and into the brain of nude rats. Brain tumour sections were examined for various known tumour markers by routine haematoxylin and eosin staining and immunohistochemical analyses. RESULTS The immunohistochemical analyses showed that S100 protein, glial fibrillary acidic protein and synaptophysin expressions, initially present in tissue culture, were lost in both models. Persistent kallikrein, CD68 and vimentin expressions in U87 cells, as well as in both animal tumour models, were detected. The percentage of p53-positive nuclei, which was higher in the tumours grown on the chick chorioallantoic membrane than in rats, did not correlate with the Ki-67 labelling index. Strong cathepsin expression was maintained from the cell culture to both tumour models. CD3-positive cells and numerous leukocytes, but no CD20-positive cells were detected in any of the animal samples, indicating the immunological response of the host to be primarily cellular. Stronger immune reaction for vascular endothelial growth factor in rats correlated with an observed increase in vascular proliferation in these tumours. CONCLUSION A simple, fast-growing, cheap and well-defined chick chorioallantoic membrane model of glioma was established, providing a basis for further experimental studies of genetic and protein expression during human glioma tumourigenesis. This model may possibly replace some rodent models for selective studies.

[1]  Karlyne M. Reilly,et al.  Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects , 2000, Nature Genetics.

[2]  T. Barone,et al.  Hormonal effects on glioblastoma multiforme in the nude rat model. , 1999, Journal of neurosurgery.

[3]  T. Orfeo,et al.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. , 1977, Journal of the National Cancer Institute.

[4]  G. Fuller,et al.  Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. , 2000, The American journal of pathology.

[5]  E. Lazarides.  Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. , 1982, Annual review of biochemistry.

[6]  P J Kelly,et al.  A histologic and cytologic method for the spatial definition of gliomas. , 1987, Mayo Clinic proceedings.

[7]  Bonnie F. Sloane,et al.  Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. , 1995, Journal of neurosurgery.

[8]  F. Sedaghat,et al.  S100 protein family and its application in clinical practice. , 2008, Hippokratia.

[9]  J. Cairncross,et al.  Comparison of metastatic properties of a variety of mouse, rat, and human cells in assays in nude mice and chick embryos. , 1990, In vivo.

[10]  D. Lane,et al.  A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction , 1991, The Journal of pathology.

[11]  J. Weis,et al.  Histology of human glioblastoma transplanted on chicken chorioallantoic membrane. , 2009, Medicina.

[12]  J. Cairncross,et al.  Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression , 1991, Journal of Neuro-Oncology.

[13]  B. Hall,et al.  The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts , 1978, The Journal of experimental medicine.

[14]  A. Belli,et al.  S100B in neuropathologic states: The CRP of the brain? , 2007, Journal of neuroscience research.

[15]  Douglas C. Miller,et al.  A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma Multiforme , 1993, Brain pathology.

[16]  D. Dahl.  The vimentin‐GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination , 1981, Journal of neuroscience research.

[17]  M. Esiri,et al.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas , 2004, Acta Neuropathologica.

[18]  J. Kos,et al.  Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  S. Leenstra,et al.  Human malignant astrocytes express macrophage phenotype , 1995, Journal of Neuroimmunology.

[20]  L. Ossowski,et al.  Experimental model for quantitative study of metastasis. , 1980, Cancer research.

[21]  L. de Ridder,et al.  In vitro and in vivo models for the study of brain tumour invasion. , 1997, Anticancer research.

[22]  K. Weber,et al.  Vimentin, the 57 000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia. , 1981, European journal of cell biology.

[23]  B. Smith,et al.  REGULATION OF CYTOTOXIC T LYMPHOCYTE‐MEDIATED GRAFT REJECTION FOLLOWING BONE MARROW , 1988, Transplantation.

[24]  O. Halvorsen,et al.  Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. , 2001, Anticancer research.

[25]  Timothy C Ryken,et al.  Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. , 2006, Neurosurgical focus.

[26]  P. Vrignaud,et al.  Assessment of the experimental model of transplanted C6 glioblastoma in wistar rats , 1989, Journal of Neuro-Oncology.

[27]  F. Ramaekers,et al.  Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas , 2004, Acta Neuropathologica.

[28]  D. Silbergeld,et al.  Isolation and characterization of human malignant glioma cells from histologically normal brain. , 1997, Journal of neurosurgery.

[29]  P. Burger,et al.  Macrophage Markers in Diagnostic Neuropathology , 1992, The American journal of surgical pathology.

[30]  O. Olopade,et al.  Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. , 1992, Cancer research.

[31]  J. Bussink,et al.  Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. , 2009, Microvascular research.

[32]  B. Scheithauer,et al.  Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. , 1997, Journal of neurosurgery.

[33]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[34]  B. Wiedenmann,et al.  Synaptophysin: A reliable marker for medulloblastomas , 2004, Virchows Archiv A.

[35]  T. Strojnik,et al.  Cathepsin L in glioma progression: comparison with cathepsin B. , 2005, Cancer detection and prevention.

[36]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[37]  J. Pontén,et al.  Long term culture of normal and neoplastic human glia. , 2009, Acta pathologica et microbiologica Scandinavica.

[38]  G. Ricevuti,et al.  Neutrophil infiltration into human gliomas , 1999, Acta Neuropathologica.

[39]  Andreas Bikfalvi,et al.  Accessing key steps of human tumor progression in vivo by using an avian embryo model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Wilson,et al.  Direct comparison of bromodeoxyuridine and Ki‐67 labelling indices in human tumours , 1996, Cell proliferation.

[41]  T. Strojnik,et al.  Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. , 2006, Anticancer research.

[42]  G. Nicolson,et al.  Overexpression and localization of cathepsin B during the progression of human gliomas , 2004, Clinical & Experimental Metastasis.